CJC-1295 + GHRP-2 (10mg Vial) Dosage Protocol

Quickstart Highlights

CJC-1295 + GHRP-2 (10mg) dosage protocol is commonly used to support growth hormone (GH) release, with research suggesting potential benefits in body composition and recovery. This blend typically splits the vial into ~5mg of CJC-1295 and ~5mg of GHRP-2.

  • Often administered 1–2 times per day, 5 days per week
  • Can be reconstituted with up to 3 mL for more accurate dosing
  • Avoid extremely low “units” by using larger dilution volumes or smaller syringes
  • Store lyophilized in the freezer and reconstituted in the refrigerator
  • Protocol durations generally range 8–16 weeks
CJC-1295 + GHRP-2 Vial

Dosing & Reconstitution Guide

Educational guide for reconstitution and dosing protocol

Standard / Gradual Approach (3 mL Reconstitution)

Weeks Dose per Injection (mcg) Units (per injection) Frequency
1–4 300 mcg total (≈150 mcg each peptide) ~9 units 2x daily, 5 days/week
5–8 400 mcg total (≈200 mcg each peptide) ~12 units 2x daily, 5 days/week

Reconstituting with 3 mL keeps injection volume manageable. If doses under ~10 units are needed, consider using 50-unit or 30-unit insulin syringes for better precision.

  1. Draw 3.0 mL of bacteriostatic water into a sterile syringe.
  2. Inject slowly along the vial wall to minimize foaming.
  3. Gently swirl—avoid vigorous shaking.
  4. Label the vial (date) and store at 2–8°C.
  5. Use within 30 days; keep reconstituted vial refrigerated.

Advanced / Aggressive Approach (2 mL Reconstitution)

Weeks Dose per Injection (mcg) Units (per injection) Frequency
1–4 500 mcg total (≈250 mcg each peptide) 10 units 2x daily, 5 days/week
5–8 600 mcg total (≈300 mcg each peptide) 12 units 2x daily, 5 days/week
9–12 (Optional) 800 mcg total (≈400 mcg each peptide) 16 units 2x daily, 5 days/week

For those seeking more pronounced effects, reconstitute with 2 mL (5 mg/mL). Each unit on a 100-unit syringe will deliver ~50 mcg of the total blend.

  1. Draw 2.0 mL of bacteriostatic water into a sterile syringe.
  2. Slowly inject along the vial interior to prevent foam.
  3. Gently roll/swirl—no vigorous shaking.
  4. Refrigerate at 2–8°C and use within 30 days.
  5. Avoid freeze-thaw cycles for best peptide stability.

Note: This guide is for educational purposes only. Always consult a qualified professional.

Protocol Overview

A concise summary of CJC-1295 + GHRP-2 daily-injection strategies.

  • Goal: Enhance GH release to support muscle maintenance and recovery
  • Schedule: Typically 2 injections per day, 5 days on / 2 days off
  • Dose Range: 300–800 mcg total per injection, depending on tolerance
  • Reconstitution: Up to 3 mL to maintain measurable dosing units
  • Storage: Freeze lyophilized; refrigerate (2–8°C) once mixed

Dosing Protocol

Split daily doses to align with natural GH pulses. An empty stomach (2–3 hours post-meal) is recommended.

  • Frequency: 1–2 injections per day (morning and/or before bedtime)
  • Cycle Length: 8–16 weeks, with possible breaks after completion
  • Weekly Schedule: 5 days on, 2 days off for recovery
  • Injection Sites: Subcutaneous (abdomen, thigh, or upper arm)
  • Adjustments: Increase gradually to manage any side effects

Storage Instructions

Proper storage preserves the peptide’s potency and integrity.

  • Lyophilized: Store in freezer (−20°C) until ready to mix
  • Reconstituted: Keep refrigerated at 2–8°C
  • Use within 30 days of mixing
  • Minimize temperature fluctuations and avoid freeze-thaw cycles

Supplies Needed

Gather these materials for an 8–16 week peptide cycle.

  • Peptide Vials:
    • 8 wks ≈ 2 vials
    • 12 wks ≈ 3 vials
    • 16 wks ≈ 4 vials
    (Higher doses or longer cycles may require more)
  • Insulin Syringes:
    • 8 wks ≈ 10–16
    • 12 wks ≈ 20+
    • 16 wks ≈ 30+
    (Consider 50-unit or 30-unit syringes if dosing below ~10 units)
  • Bacteriostatic Water: 1× 30ml (or more as needed)
  • Alcohol Swabs: 1 box
CJC-1295 + GHRP-2 Vial View Supplier
Insulin Syringes View Supplier
Bacteriostatic Water View Supplier
Alcohol Pads View Supplier

Important Notes

Practical tips to enhance safety and efficacy.

  • Always use new, sterile insulin syringes & rotate injection sites.
  • Take doses on an empty stomach (2–3 hours after your last meal).
  • Monitor for side effects and discontinue if adverse reactions occur.
  • Document progress weekly; adjust dosage only if advised by a professional.

How This Works

CJC-1295 and GHRP-2 act on separate pathways to amplify growth hormone (GH) release.

  • CJC-1295: A growth hormone-releasing hormone (GHRH) analog that promotes sustained GH release
  • GHRP-2: A ghrelin mimetic that triggers additional GH secretion via the GHS-R pathway
  • Combined use may enhance GH pulsatility, supporting muscle repair and metabolism

Potential Benefits & Side Effects

Users often report improved recovery and body composition, though experiences vary.

  • May help maintain lean muscle and improve workout recovery
  • Potential mild side effects include headache, flushing, or injection-site irritation
  • Some individuals note increased appetite (common with GHRP peptides)
  • Any severe or persistent side effects warrant professional evaluation

Lifestyle Factors

Complement the protocol with these healthy habits.

  • Maintain a balanced diet with sufficient protein
  • Regular resistance training and cardiovascular exercise
  • Prioritize adequate sleep and stress management

Injection Technique

Simple guidelines for safe daily injections.

  • Clean vial rubber stopper & injection site with alcohol swabs
  • Insert needle at a 45–90° angle into subcutaneous tissue
  • Inject slowly & rotate sites (abdomen, thigh, etc.)

Important Note

This guide is for educational purposes only. Always consult a qualified healthcare provider before starting or modifying any therapy.

References

  • PubMed – GH release findings in human subjects
    View Source
  • FDA Document – Regulatory guidance on GH peptides
    View Source
  • AJP Endocrinology – Investigates GH and IGF-1 regulation
    View Source
  • Asian-Australasian J Anim Sci – Animal model research on GH peptides
    View Source
  • Wiley Online Library – Study examining metabolic hormone interactions
    View Source
  • Medsafe.govt.nz – Government review on performance enhancers
    View Source
  • Sciensano – Belgian research exploring endocrine pathways
    View Source

 

Enhanced Footer Example